Search Share Prices
AZN Headlines - AstraZeneca shares gain after drug shows success in late-stage hypertension trial
Baxdrostat is one of several drugs AstraZeneca is developing in cardiovascular, renal, and metabolic disease areas. The company gained rights to the drug in 2023 after acquiring CinCor Pharma in a ...
AstraZeneca exit: here’s what it really means for the UK
AstraZeneca is reportedly considering moving its listing to the US. Here's why AZN's expected departure is alarming for the UK.
AstraZeneca completes EsoBiotec acquisition for up to $1bn
AstraZeneca PLC (LSE/STO/Nasdaq:LON: AZN), the global biopharmaceutical company, has announced the completion of its acquisition of EsoBiotec, a biotech company specializing in cell therapies, for a ...
AstraZeneca (LON:AZN) Is Posting Promising Earnings But The Good News ...
AstraZeneca PLC (LON:AZN) announced a healthy earnings result recently, and the market rewarded it with a strong uplift in the stock price. This reaction by the market reaction is understandable when ...
AstraZeneca's new 2030 targets are bold attempt to reach for the stars ...
Proactive Investors - After AstraZeneca PLC (LON: AZN) unveiled new sales and profit targets for the end of the decade, analysts were mildly impressed by the ambition to "shoot for the stars".